Announced
Synopsis
Gryphon Investors-backed Vetnique Labs, a pet health products company, agreed to acquire Lintbells, a pet supplements provider. Financial terms were not disclosed. "Our vision with Gryphon has always been to create a global pet health and wellness platform in the $3bn supplement market. We are excited to build on our track record of profitable growth and help accelerate YuMOVE's products in North America. Together we can broaden our offering of differentiated products and solutions that are consistently recommended by veterinarians and provide real and lasting benefits for pets," James Bascharon, Vetnique CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.